Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Treprostinil reduces economic burden associated with IPAH

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Treprostinil reduces economic burden associated with IPAH. Pharmacoecon. Outcomes News 494, 11 (2006). https://doi.org/10.2165/00151234-200604940-00035

    Download citation

    Keywords

    • Cost Saving
    • Outcome News
    • Economic Burden
    • Report Researcher
    • Bosentan